Lamivudine therapy for hepatitis B in renal transplantation
Texto
Imagem
Documentos relacionados
Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes.. Francisco Campello do Amaral Mello 1
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and im- pact on renal transplantation. Cytomegalovirus in- fection
ETV, in comparison with LVD, resulted in a lower cost per patient reaching undetectable viral load, a lower cost per life- year saved and a lower cost per QALY gained, in both
Com o intuito de criar dentro da Operação CMIP um processo piloto para a implementação de um BPMS de forma a demonstrar as mais valias da extensão do projeto, para as mais diversas
With the renal replacement therapy (dialysis and transplant), there were great advances in nephrology, as well as an increase in the survival rates of patients with ESRD and the
We present two cases of patients with a history of renal lithiasis who were diagnosed with pri- mary hyperoxaluria in the post-transplant period, manifested by early graft failure,
Hydroxyethyl starches solutions must be avoided in septic patients due to the increased risk of acute renal failure, increased need for renal replacement therapy and
The better survival of pancreatic (86%) and renal (93%) grafts in the first year after transplantation is in the simultaneous pancreas-kidney transplant group of